南方医科大学学报 ›› 2014, Vol. 34 ›› Issue (08): 1215-.
• • 上一篇 下一篇
刘敏龙,王国恩,马琪,任俊明,郭蕾,张军
出版日期:
发布日期:
Online:
Published:
摘要: 目的探讨消化道大出血的治疗。方法重组人凝血因子VIIa(rFVIIa)是一种凝血因子制剂,国外文献报道可控制危及生命的出血。1例78岁的消化道大出血患者合并肾衰呼吸衰竭,经过常规药物治疗无效,出血持续,出现休克。应用rFVIIa20 μg/kg静脉注射治疗。结果出血迅速控制,生命体征逐渐稳定。结论对于常规方法无法控制的消化道大出血,rFVIIa可作为尝试治疗。
Abstract: Recombinant activated factor VII (rFVIIa) is a novel therapeutic agent for life-threatening massive gastrointestinalbleeding. We report a case of massive gastrointestinal bleeding in a 78-year-old female patient with respiratory and renal failure.After failure of management of the bleeding with routine pharmacotherapy, we gave the patient rFVIIa injection at thedose of 20 μg/kg and the bleeding was rapidly controlled. Adverse side effects of the drug were not observed in this patient.
刘敏龙,王国恩,马琪,任俊明,郭蕾,张军. rFVIIa 成功控制合并肾衰呼吸衰竭的消化道大出血1例[J]. 南方医科大学学报, 2014, 34(08): 1215-.
0 / / 推荐
导出引用管理器 EndNote|Ris|BibTeX
链接本文: https://www.j-smu.com/CN/
https://www.j-smu.com/CN/Y2014/V34/I08/1215